New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
10:48 EDTAMRNAmarin shares slightly lower after FDA updates Orange Book
Amarin shares are down 10c, or 1.15%, to $8.57 after an update in the FDA's Orange Book regarding the company's drug Vascepa said, "There is no unexpired exclusivity for this product." The FDA posting noted that the Orange Book Data was updated through January, 2013 and that patent and generic drug product data was last updated on February 19. Reference Link
News For AMRN From The Last 14 Days
Check below for free stories on AMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AMRN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use